Therapeutic plasma exchange in systemic vasculitis: An update on indications and results

Current Opinion in Rheumatology

Volumn 24, Issue 3, 2012, Pages 261-266

  Mahr, Alfred ^a   Chaigne Delalande, Séverin ^b   De Menthon, Mathilde ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

antiglomerular basement membrane disease; antineutrophil cytoplasmic antibodies associated vasculitis; cryoglobulinemic vasculitis; Henoch Sch nlein purpura; Kawasaki disease; plasma exchange; plasmapheresis; polyarteritis nodosa; vasculitis

Indexed keywords

CYCLOPHOSPHAMIDE; FRESH FROZEN PLASMA; GLUCOCORTICOID; HUMAN SERUM ALBUMIN; IMMUNOSUPPRESSIVE AGENT;

ALLERGIC REACTION; ANAPHYLACTOID PURPURA; ANAPHYLAXIS; ANCA ASSOCIATED VASCULITIS; ANTIBODY PRODUCTION; BLEEDING; BLEEDING TENDENCY; CELL SEPARATION; CHURG STRAUSS SYNDROME; CLINICAL EFFECTIVENESS; DISEASE SEVERITY; FOLLOW UP; GLOMERULONEPHRITIS; HEMODIALYSIS; HUMAN; HYPOCALCEMIA; HYPOTENSION; IDIOPATHIC DISEASE; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; META ANALYSIS (TOPIC); MORTALITY; MUCOCUTANEOUS LYMPH NODE SYNDROME; OUTCOME ASSESSMENT; PLASMAPHERESIS; POLYARTERITIS NODOSA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SEROCONVERSION; SMALL VESSEL VASCULITIS; SYSTEMIC VASCULITIS; TREATMENT INDICATION;

AUTOIMMUNE DISEASES; HUMANS; IMMUNE COMPLEX DISEASES; MUCOCUTANEOUS LYMPH NODE SYNDROME; PLASMA EXCHANGE; SYSTEMIC VASCULITIS; TREATMENT OUTCOME;

EID: 84859229891     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0b013e3283526509     Document Type: Review

References (51)

1. Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med 1997; 337:1512-1523. (Pubitemid 27495778)
2. Savage CO, Harper L, Adu D. Primary systemic vasculitis. Lancet 1997; 349:553-558. (Pubitemid 27092803)
3. Lockwood CM, Boulton-Jones JM, Lowenthal RM, et al. Recovery from Goodpasture's syndrome after immunosuppressive treatment and plasmapheresis. Br Med J 1975; 2:252-254.
4. Hanafusa N. Theoretical basis of pathogenic substance removal during plasmapheresis. Ther Apher Dial 2011; 15:421-430.
5. Ward DM. Conventional apheresis therapies: a review. J Clin Apher 2011; 26:230-238.
6. Basic-Jukic N, Kes P, Glavas-Boras S, et al. Complications of therapeutic plasma exchange: experience with 4857 treatments. Ther Apher Dial 2005; 9:391-395. (Pubitemid 43943059)
7. Stegmayr B, Ptak J, Wikstrom B, et al. World apheresis registry 2003-2007 data. Transfus Apher Sci 2008; 39:247-254.
8. Sanders JS, Rutgers A, Stegeman CA, Kallenberg CG. Pulmonary: renal syndrome with a focus on anti-GBM disease. Semin Respir Crit Care Med 2011; 32:328-334.
9. Wilson CB, Dixon FJ. Antiglomerular basement membrane antibody-induced glomerulonephritis. Kidney Int 1973; 3:74-89.
10. Johnson JP, Moore J Jr, et al. Therapy of antiglomerular basement membrane antibody disease: analysis of prognostic significance of clinical, pathologic and treatment factors. Medicine (Baltimore) 1985; 64:219-227. (Pubitemid 16247105)
11. Cui Z, Zhao J, Jia XY, et al. Antiglomerular basement membrane disease: outcomes of different therapeutic regimens in a large single-center Chinese Cohort Study. Medicine (Baltimore) 2011; 90:303-311.
12. Levy JB, Turner AN, Rees AJ, Pusey CD. Long-term outcome of antiglomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 2001; 134:1033-1042 (Pubitemid 32488657)
13. Flossmann O, Berden A, de Groot K, et al. Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis 2011; 70:488-494
14. Jayne DR, Gaskin G, Rasmussen N, et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 2007; 18:2180-2188 (Pubitemid 47041083)
15. Walsh M, Catapano F, Szpirt W, et al. Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a meta-analysis. Am J Kidney Dis 2011;57:566-574.
16. Szpirt WM, Heaf JG, Petersen J. Plasma exchange for induction and cyclosporine A for maintenance of remission in Wegener's granulomatosis: a clinical randomized controlled trial. Nephrol Dial Transplant 2011; 26:206-213.
17. Mukhtyar C, Guillevin L, Cid MC, et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 2009; 68:310-317
18. Klemmer PJ, Chalermskulrat W, Reif MS, et al. Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. Am J Kidney Dis 2003; 42:1149-1153 (Pubitemid 37486757)
19. Roberts PF, Waller TA, Brinker TM, et al. Henoch-Schonlein purpura: a review article. South Med J 2007; 100:821-824
20. Gianviti A, Trompeter RS, Barratt TM, et al. Retrospective study of plasma exchange in patients with idiopathic rapidly progressive glomerulonephritis and vasculitis. Arch Dis Child 1996; 75:186-190 (Pubitemid 26313260)
21. Kawasaki Y, Suzuki J, Murai M, et al. Plasmapheresis therapy for rapidly progressive Henoch-Schonlein nephritis. Pediatr Nephrol 2004; 19:920-923 (Pubitemid 39144779)
22. Acar B, Arikan FI, Alioglu B, et al. Successful treatment of gastrointestinal involvement in Henoch-Schonlein purpura with plasmapheresis. Pediatr Nephrol 2008; 23:2103
23. Wortmann SB, Fiselier TJ, Van De Kar NC, et al. Refractory severe intestinal vasculitis due to Henoch-Schonlein purpura: successful treatment with plasmapheresis. Acta Paediatr 2006; 95:622-623 (Pubitemid 43791588)
24. Donghi D, Schanz U, Sahrbacher U, et al. Life-threatening or organ-impairing Henoch-Schonlein purpura: plasmapheresis may save lives and limit organ damage. Dermatology 2009; 219:167-170
25. Hattori M, Ito K, Konomoto T, et al. Plasmapheresis as the sole therapy for rapidly progressive Henoch-Schonlein purpura nephritis in children. Am J Kidney Dis 1999; 33:427-433 (Pubitemid 29107018)
26. Shenoy M, Ognjanovic MV, Coulthard MG. Treating severe Henoch-Schonlein and IgA nephritis with plasmapheresis alone. Pediatr Nephrol 2007; 22:1167-1171
27. Pietrogrande M, De Vita S, Zignego AL, et al. Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virusinfected patients. Autoimmun Rev 2011; 10:444-454
28. Scarpato S, Tirri E, Naclerio C, et al. Plasmapheresis in cryoglobulinemic neuropathy: a clinical study. Dig Liver Dis 2007; 39 (Suppl 1):S136-S137 (Pubitemid 47528204)
29. Stefanutti C, Vivenzio A, Di Giacomo S, et al. Immunoadsorption apheresis and immunosuppressive drug therapy in the treatment of complicated HCV-related cryoglobulinemia. J Clin Apher 2009; 24:241-246
30. Rockx MA, Clark WF. Plasma exchange for treating cryoglobulinemia: a descriptive analysis. Transfus Apher Sci 2010; 42:247-251.
31. Guillevin L, Lhote F, Leon A, et al. Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges: a prospective trial in 33 patients. J Rheumatol 1993; 20:289-298 (Pubitemid 23066041)
32. Guillevin L, Lhote F, Sauvaget F, et al. Treatment of polyarteritis nodosa related to hepatitis B virus with interferon-alpha and plasma exchanges. Ann Rheum Dis 1994; 53:334-337 (Pubitemid 24164979)
33. Guillevin L, Mahr A, Cohen P, et al. Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa. Arthritis Rheum 2004; 51:482-487 (Pubitemid 38725151)
34. Filer A, Hughes A, Kane K, et al. Successful treatment of hepatitis B-associated vasculitis using lamivudine as the sole therapeutic agent. Rheumatology (Oxford) 2001; 40:1064-1065 (Pubitemid 32910449)
35. Guillevin L, Lhote F, Gayraud M, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome: a prospective study in 342 patients. Medicine (Baltimore) 1996; 75:17-28 (Pubitemid 26041085)
36. Villain E, Kachaner J, Sidi D, et al. Trial of prevention of coronary aneurysm in Kawasaki's disease using plasma exchange or infusion of immunoglobulins [French]. Arch Fr Pediatr 1987; 44:79-83 (Pubitemid 17036359)
37. Hokosaki T, Mori M, Nishizawa T, et al. Long-term efficacy of plasma exchange treatment for refractory Kawasaki disease. Pediatr Int 2012; 54:99-103.
38. Mori M. Plasma exchange therapy for Kawasaki disease refractory to intravenous immunoglobulin [in Japanese]. Nihon Rinsho 2008; 66:349-354
39. Imagawa T, Mori M, Miyamae T, et al. Plasma exchange for refractory Kawasaki disease. Eur J Pediatr 2004; 163:263-264 (Pubitemid 38657183)
40. Takagi N, Kihara M, Yamaguchi S, et al. Plasma exchange in Kawasaki disease. Lancet 1995; 346:1307
41. Harada T, Ito S, Shiga K, et al. A report of two cases of Kawasaki disease treated with plasma exchange. Ther Apher Dial 2008; 12:176-179 (Pubitemid 351490254)
42. Guillevin L, Cevallos R, Durand-Gasselin B, et al. Treatment of glomerulonephritis in microscopic polyangiitis and Churg-Strauss syndrome. Indications of plasma exchanges, Meta-analysis of 2 randomized studies on 140 patients, 32 with glomerulonephritis. Ann Med Interne (Paris) 1997; 148:198-204
43. Guillevin L, Fain O, Lhote F, et al. Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome: a prospective, randomized trial in 78 patients. Arthritis Rheum 1992; 35:208-215
44. Guillevin L, Lhote F, Cohen P, et al. Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis: a prospective, randomized trial in sixty-two patients. Arthritis Rheum 1995; 38:1638-1645
45. Raizman MB, Foster CS. Plasma exchange in the therapy of Behcet's disease. Graefes Arch Clin Exp Ophthalmol 1989; 227:360-363 (Pubitemid 19180486)
46. You B, Lardenet F, Schooneman F, Grillat JP. Plasma exchange in the treatment of Behcet's disease: preliminary study apropos of 7 cases [French]. Rev Med Interne 1983; 4:231-235 (Pubitemid 13019707)
47. Bonnet M, Ouzan D, Trepo C. Plasma exchange and acyclovir in Behcet's disease [in French]. J Fr Ophtalmol 1986; 9:15-22 (Pubitemid 16083813)
48. Cornelis F, Sigal-Nahum M, Gaulier A, et al. Behcet's disease with severe cutaneous necrotizing vasculitis: response to plasma exchange-report of a case. J Am Acad Dermatol 1989; 21:576-579
49. Lambert D, Rifle G, Guiod-Deschamps I, Collet E. Plasma exchange in patients with Behcet's disease. J Am Acad Dermatol 1990; 22:1123 (Pubitemid 20186150)
50. Rifle G, Tanter Y, Mousson C, et al. Treatment of severe Behcet's disease by plasma exchange with or without immunosuppressive drugs: long term followup. Prog Clin Biol Res 1990; 337:331-335
51. Belova LA, Arkhapkova IA, Ogloblina OG, et al. Extracorporeal circulation methods in the treatment of nonspecific aortic arteritis [in Russian]. Ter Arkh 1998; 70:26-29. (Pubitemid 128522349)